Literature DB >> 16583434

The fourth apolipoprotein E haplotype found in the Yoruba of Ibadan.

Jill R Murrell, Brandon M Price, Olusegun Baiyewu, Oye Gureje, Mark Deeg, Hugh Hendrie, Adesola Ogunniyi, Kathleen Hall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16583434      PMCID： PMC4550481          DOI： 10.1002/ajmg.b.30295

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN： 1552-4841            Impact factor:   3.568


× No keyword cloud information.
  10 in total

1.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

2.  A simple and efficient method for apolipoprotein E genotype determination.

Authors:  J Chapman; J Estupiñan; A Asherov; L G Goldfarb
Journal:  Neurology       Date:  1996-05       Impact factor: 9.910

3.  A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy.

Authors:  M Ando; J Sasaki; H Hua; A Matsunaga; K Uchida; K Jou; S Oikawa; T Saito; H Nihei
Journal:  Kidney Int       Date:  1999-10       Impact factor: 10.612

4.  Increased expression of GPI-specific phospholipase D in mouse models of type 1 diabetes.

Authors:  M A Deeg; R F Bowen; M D Williams; L K Olson; E A Kirk; R C LeBoeuf
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-07       Impact factor: 4.310

5.  Apolipoprotein EBethesda: a new variant of apolipoprotein E associated with type III hyperlipoproteinemia.

Authors:  R E Gregg; G Ghiselli; H B Brewer
Journal:  J Clin Endocrinol Metab       Date:  1983-11       Impact factor: 5.958

6.  A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1.

Authors:  K H Weisgraber; S C Rall; T L Innerarity; R W Mahley; T Kuusi; C Ehnholm
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

7.  Apolipoprotein E1 Lys-146----Glu with type III hyperlipoproteinemia.

Authors:  K Moriyama; J Sasaki; A Matsunaga; F Arakawa; Y Takada; K Araki; S Kaneko; K Arakawa
Journal:  Biochim Biophys Acta       Date:  1992-09-22

8.  Apolipoprotein E1-Hammersmith (Lys146-->Asn;Arg147-->Trp), due to a dinucleotide substitution, is associated with early manifestation of dominant type III hyperlipoproteinaemia.

Authors:  M J Hoffer; S Niththyananthan; R P Naoumova; M S Kibirige; R R Frants; L M Havekes; G R Thompson
Journal:  Atherosclerosis       Date:  1996-08-02       Impact factor: 5.162

9.  Normolipemic dysbetalipoproteinemia and hyperlipoproteinemia type III in subjects homozygous for a rare genetic apolipoprotein E variant (apoE1).

Authors:  A Steinmetz; N Assefbarkhi; C Eltze; K Ehlenz; H Funke; A Pies; G Assmann; H Kaffarnik
Journal:  J Lipid Res       Date:  1990-06       Impact factor: 5.922

10.  Enhanced APOE2 transmission rates in families with autistic probands.

Authors:  A M Persico; L D'Agruma; L Zelante; R Militerni; C Bravaccio; C Schneider; R Melmed; S Trillo; F Montecchi; M Elia; M Palermo; D Rabinowitz; T Pascucci; S Puglisi-Allegra; K-L Reichelt; L Muscarella; V Guarnieri; J-M Melgari; M Conciatori; F Keller
Journal:  Psychiatr Genet       Date:  2004-06       Impact factor: 2.458
  10 in total
  4 in total

1.  Genetic Influences on Plasma Homocysteine Levels in African Americans and Yoruba Nigerians.

Authors:  Sungeun Kim; Kwangsik Nho; Vijay K Ramanan; Dongbing Lai; Tatiana M Foroud; Katie Lane; Jill R Murrell; Sujuan Gao; Kathleen S Hall; Frederick W Unverzagt; Olusegun Baiyewu; Adesola Ogunniyi; Oye Gureje; Mitchel A Kling; P Murali Doraiswamy; Rima Kaddurah-Daouk; Hugh C Hendrie; Andrew J Saykin
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

Review 2.  International studies in dementia with particular emphasis on populations of African origin.

Authors:  Hugh C Hendrie; Jill Murrell; Sujuan Gao; Fredrick W Unverzagt; Adesola Ogunniyi; Kathleen S Hall
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Jul-Sep       Impact factor: 2.703

Review 3.  A Quarter Century of APOE and Alzheimer's Disease: Progress to Date and the Path Forward.

Authors:  Michaël E Belloy; Valerio Napolioni; Michael D Greicius
Journal:  Neuron       Date:  2019-03-06       Impact factor: 17.173

4.  Neuroprotection and neurodegeneration in Alzheimer's disease: role of cardiovascular disease risk factors, implications for dementia rates, and prevention with aerobic exercise in african americans.

Authors:  Thomas O Obisesan; Richard F Gillum; Stephanie Johnson; Nisser Umar; Deborah Williams; Vernon Bond; John Kwagyan
Journal:  Int J Alzheimers Dis       Date:  2012-04-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.